The rise of new viruses, like SARS-CoV-2 causing the COVID-19 outbreak, along with the return of antibiotic resistance in harmful bacteria, demands a swift and efficient reaction to safeguard the health and welfare of...The rise of new viruses, like SARS-CoV-2 causing the COVID-19 outbreak, along with the return of antibiotic resistance in harmful bacteria, demands a swift and efficient reaction to safeguard the health and welfare of the global population. It is crucial to have effective measures for prevention, intervention, and monitoring in place to address these evolving and recurring risks, ensuring public health and international security. In countries with limited resources, utilizing recombinant mutation plasmid technology in conjunction with PCR-HRM could help differentiate the existence of novel variants. cDNA synthesis was carried out on 8 nasopharyngeal samples following viral RNA extraction. The P1 segment of the SARS-CoV-2 Spike S protein was amplified via conventional PCR. Subsequently, PCR products were ligated with the pGEM-T Easy vector to generate eight recombinant SARS-CoV-2 plasmids. Clones containing mutations were sequenced using Sanger sequencing and analyzed through PCR-HRM. The P1 segment of the S gene from SARS-CoV-2 was successfully amplified, resulting in 8 recombinant plasmids generated from the 231 bp fragment. PCR-HRM analysis of these recombinant plasmids differentiated three variations within the SARS-CoV-2 plasmid population, each displaying distinct melting temperatures. Sanger sequencing identified mutations A112C, G113T, A114G, G214T, and G216C on the P1 segment, validating the PCR-HRM findings of the variations. These mutations led to the detection of L452R or L452M and F486V protein mutations within the protein sequence of the Omicron variant of SARS-CoV-2. In summary, PCR-HRM is a vital and affordable tool for distinguishing SARS-CoV-2 variants utilizing recombinant plasmids as controls.展开更多
根据猪链球菌16 S rDNA基因的种特异性基因序列和CPS基因的2型(1或/和2型)型特异基因序列设计了4条引物,建立了快速检测猪链球菌2型(1或/和2型)的多重PCR方法。利用保存的猪链球菌2型菌株和其他相关标准菌株作为参考菌株对该方法进行了...根据猪链球菌16 S rDNA基因的种特异性基因序列和CPS基因的2型(1或/和2型)型特异基因序列设计了4条引物,建立了快速检测猪链球菌2型(1或/和2型)的多重PCR方法。利用保存的猪链球菌2型菌株和其他相关标准菌株作为参考菌株对该方法进行了敏感性和特异性试验。结果显示,所建立的多重PCR方法特异、敏感,对组织中的猪链球菌2型(1或/和2型)的最低检出水平为30 CFU/mL。用所建立的多重PCR方法对采自江西、北京、珠海、天津、四川等省市的猪扁桃体样品进行了检测,并通过细菌分离和玻片凝集试验对其检测结果进行了验证,结果显示,检出阳性符合率为100%,证实建立的多重PCR方法可用于猪链球菌2型的快速检测。展开更多
文摘目的本研究旨在建立一种实时荧光定量PCR方法,用于检测猕猴三磷酸腺苷结合盒转运蛋白G2(adenosine triphosphate-binding cassette transporter protein G2,ABCG2)mRNA的基因转录水平。方法使用NCBI上GenBank数据库猕猴(Macaca mulatta)的ABCG2核苷酸序列号NM_001032919.1及内参GAPDH核苷酸序列号NM_001195426.1,借助Primer premier 5.0软件设计PCR引物。提取猕猴新鲜肾组织的总RNA,并反转录合成cDNA。接着,利用PCR引物进行实时荧光定量PCR扩增,并根据反应体系中荧光的变化情况定量分析ABCG2的mRNA相对表达水平。结果PCR产物测序结果显示,扩增的ABCG2和GAPDH核苷酸序列与NCBI上猕猴的序列同源性分别为90.91%和91.14%。ABCG2和GAPDH的扩增效率均达到80%~120%,实时荧光定量PCR标准曲线的熔解曲线为单峰,R2接近1。结论本研究建立的检测猕猴ABCG2 mRNA实时荧光定量检测方法,为研究高尿酸血症的发病机制以及新药开发奠定基础。
文摘The rise of new viruses, like SARS-CoV-2 causing the COVID-19 outbreak, along with the return of antibiotic resistance in harmful bacteria, demands a swift and efficient reaction to safeguard the health and welfare of the global population. It is crucial to have effective measures for prevention, intervention, and monitoring in place to address these evolving and recurring risks, ensuring public health and international security. In countries with limited resources, utilizing recombinant mutation plasmid technology in conjunction with PCR-HRM could help differentiate the existence of novel variants. cDNA synthesis was carried out on 8 nasopharyngeal samples following viral RNA extraction. The P1 segment of the SARS-CoV-2 Spike S protein was amplified via conventional PCR. Subsequently, PCR products were ligated with the pGEM-T Easy vector to generate eight recombinant SARS-CoV-2 plasmids. Clones containing mutations were sequenced using Sanger sequencing and analyzed through PCR-HRM. The P1 segment of the S gene from SARS-CoV-2 was successfully amplified, resulting in 8 recombinant plasmids generated from the 231 bp fragment. PCR-HRM analysis of these recombinant plasmids differentiated three variations within the SARS-CoV-2 plasmid population, each displaying distinct melting temperatures. Sanger sequencing identified mutations A112C, G113T, A114G, G214T, and G216C on the P1 segment, validating the PCR-HRM findings of the variations. These mutations led to the detection of L452R or L452M and F486V protein mutations within the protein sequence of the Omicron variant of SARS-CoV-2. In summary, PCR-HRM is a vital and affordable tool for distinguishing SARS-CoV-2 variants utilizing recombinant plasmids as controls.
文摘根据猪链球菌16 S rDNA基因的种特异性基因序列和CPS基因的2型(1或/和2型)型特异基因序列设计了4条引物,建立了快速检测猪链球菌2型(1或/和2型)的多重PCR方法。利用保存的猪链球菌2型菌株和其他相关标准菌株作为参考菌株对该方法进行了敏感性和特异性试验。结果显示,所建立的多重PCR方法特异、敏感,对组织中的猪链球菌2型(1或/和2型)的最低检出水平为30 CFU/mL。用所建立的多重PCR方法对采自江西、北京、珠海、天津、四川等省市的猪扁桃体样品进行了检测,并通过细菌分离和玻片凝集试验对其检测结果进行了验证,结果显示,检出阳性符合率为100%,证实建立的多重PCR方法可用于猪链球菌2型的快速检测。
